Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02757352

Public ClinicalTrials.gov record NCT02757352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 1:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).

Study identification

NCT ID
NCT02757352
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
303 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2, 2016 (Actual)
Primary completion
Mar 1, 2019 (Actual)
Completion
May 7, 2019 (Actual)
Last update posted
Mar 13, 2020

2016 – 2019

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032 —
TriWest Research Assocaites El Cajon California 92020 —
Rheumatology Center of San Diego Escondido California 92025 —
Care Access Research - Huntington Beach Huntington Beach California 92648 —
Desert Medical Advances Palm Desert California 92260 —
Inlande Rheumatology Clinical Trials Upland California 91786 —
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920 —
Clinical Research Center of CT/NY Danbury Connecticut 06810 —
Sarasota Arthritis Center Sarasota Florida 34239 —
West Broward Rheumatology Associates, Inc Tamarac Florida 33321 —
Marietta Rheumatology Marietta Georgia 30060 —
Institute of Arthritis Research Idaho Falls Idaho 83404 —
The Arthritis & Diabetes Clinic Inc. Monroe Louisiana 71203 —
Osteoporosis And Clinical Trial Center Cumberland Maryland 21502 —
Osteoporosis And Clinical Trial Center Hagerstown Maryland 21740 —
Glacier View Research Institute Kalispell Montana 59901 —
Physician Research Collaboration, LLC Lincoln Nebraska 68516 —
Weill Cornell Physicians at Brooklyn Heights Brooklyn New York 11201 —
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617 —
Carolina Arthritis Associates Wilmington North Carolina 28401 —
Oregon Health and Science University Portland Oregon 97239 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204 —
Seattle Rheumatology Associates, P.L.L.C. Seattle Washington 98122 —
Arthritis Northwest Rheumatology Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02757352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2020 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02757352 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →